Gastrointestinal (GI) protection for patients with COVID-19

New tutorial available now
Steroids became standard care for patients with severe COVID-19, however an increase in gastrointestinal (GI) bleeds was observed. A proton pump inhibitor (PPI) was recommended to reduce the risk of GI bleeds and to protect the stomach from injury.
In this tutorial, we are joined by Sarah Gage, Gastrointestinal Pharmacist, who provides a background of GI protection in COVID-19 patients, some of the recommendations for their use, and other clinical considerations.

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk